Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 4/20 | 0.73 |
| ▸ | CACNA1D | Q01668 | 4/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.73 |
| ▸ | CACNA1F | O60840 | 3/20 | 0.73 |
| ▸ | CACNA1S | Q13698 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.73 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.73 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.73 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.73 |
| ▸ | SCN1A | P35498 | 2/20 | 0.73 |
| ▸ | HTR2B | P41595 | 2/20 | 0.73 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.73 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.73 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.73 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29358809 | 1.00 | CACNA1C (0.73) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL9138577 | 0.95 | CACNA1C (0.67) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL8048696 | 0.91 | ADORA3 (0.90) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL16272636 | 0.91 | CACNA1C (0.62) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL8091424 | 0.89 | CACNA1C (0.70) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL612520 | 0.88 | CACNA1C (0.73) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL4608748 | 0.88 | CACNA1C (0.73) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| SCHEMBL29004553 | 0.87 | CACNA1C (0.57) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| Nifedipine SCHEMBL3968 | 0.85 | ADORA3 (1.00) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S | |
| Nifedipine SCHEMBL1172946 | 0.85 | ADORA3 (1.00) | CACNA1CCACNA1DADORA3CACNA1FCACNA1S |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110084787-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METAL-BASE-CONTAINING CIRCUIT BOARD PRODUCTION METHOD EMPLOYING THE PHOTOSENSITIVE RESIN COMPOSITION, AND METAL-BASE-CONTAINING CIRCUIT BOARD | NITTO DENKO CORPORATION (JP) | 2011-04-14 | — | — | US | claimed |
| US-7641821-B2 | Process of manufacturing optical waveguide and connection structure of optical devices | NITTO DENKO CORPORATION (JP) | 2010-01-05 | — | — | US | claimed |
| US-20040178522-A1 | Process of manufacturing optical waveguide and connection structure of optical devices | NITTO DENKO CORPORATION | 2004-09-16 | — | — | US | claimed |
| EP-1441243-A1 | Process of manufacturing optical waveguide and connection structure of optical devices | NITTO DENKO CORPORATION (JP) | 2004-07-28 | — | — | EP | claimed |
| US-5851736-A | Heat-resistant photoresist composition, photosensitive substrate, and process for forming heat-resistant positive or negative pattern | NITTO DENKO CORPORATION (JP) | 1998-12-22 | — | — | US | claimed |
| EP-0578177-B1 | Heat-resistant negative photoresist composition, photosensitive substrate, and process for forming negative pattern | NITTO DENKO CORP (JP) | 1997-03-05 | — | — | EP | claimed |
| EP-0578177-A2 | Heat-resistant negative photoresist composition, photosensitive substrate, and process for forming negative pattern | NITTO DENKO CORPORATION (JP) | 1994-01-12 | — | — | EP | claimed |
| US-12607931-B2 | Photosensitive transfer material, light shielding material, LED array, and electronic apparatus | FUJIFILM CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12479960-B2 | Triazine ring-containing polymer and film forming composition containing same | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12426166-B2 | Method of manufacturing conductive pattern, touch sensor, electromagnetic wave shield, antenna, wiring board, conductive heating element, and structure | FUJIFILM CORPORATION (JP) | 2025-09-23 | — | — | US | disclosed |
| WO-2025013746-A1 | PATTERN-FORMING COMPOSITION | 日産化学株式会社 | 2025-01-16 | — | — | WO | disclosed |
| CN-118235091-A | Transfer film, laminate having conductor pattern, method for producing laminate having conductor pattern, and method for producing transfer film | 富士胶片株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-117940848-A | Transfer film, method for producing transfer film, method for forming pattern, method for producing circuit wiring, and method for producing touch panel | 富士胶片株式会社 | 2024-04-26 | — | — | CN | disclosed |
| EP-0171748-A2 | Negative-toning imaging system with re-imaging capability using 4-(2'-nitrophenyl)-1,4-Dihydropyridine compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-02-19 | — | — | EP | disclosed |
| EP-0017772-B1 | METHOD OF IMPROVING THE SOLUBILITY OF BIOLOGICALLY ACTIVE AGENTS IN WATER AND IN LOWER ALIPHATIC ALCOHOLS, AND COMPOUNDS HAVING AN IMPROVED SOLUBILITY | BAYER AG (DE) | 1982-07-28 | — | — | EP | disclosed |
| EP-0014263-B1 | METHOD OF IMPROVING THE SOLUBILITY OF BIOLOGICALLY ACTIVE AGENTS IN WATER AND IN LOWER ALIPHATIC ALCOHOLS, AND COMPOUNDS HAVING AN IMPROVED SOLUBILITY | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
| US-4269933-A | PHOTOLITHOGRAPHY; POSITIVE AND NEGATIVE IMAGES; POLYMERIZATION OF A UNSATURATED POLYESTER USING A PHOTOSENSITIVE FREE RADICAL SYSTEM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| EP-0017772-A1 | Method of improving the solubility of biologically active agents in water and in lower aliphatic alcohols, and compounds having an improved solubility | BAYER AG (DE) | 1980-10-29 | — | — | EP | disclosed |
| EP-0014263-A2 | Method of improving the solubility of biologically active agents in water and in lower aliphatic alcohols, and compounds having an improved solubility | BAYER AG (DE) | 1980-08-20 | — | — | EP | disclosed |
| US-4198242-A | Photopolymerizable composition containing an o-nitroaromatic compound as photoinhibitor | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607931-B2 | Photosensitive transfer material, light shielding material, LED array, and electronic apparatus | SETD1B, NLRP1, MAP1LC3B | CACNA1C 3494/4885CACNA1D 2431/4885ADORA3 2925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.